Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington’s disease mice.

Amanda J Kedaigle, Jack C Reidling, Ryan G Lim, Miriam Adam, Jie Wu, Brook Wassie, Jennifer T Stocksdale, Malcolm S Casale, Ernest Fraenkel, Leslie M Thompson